tirzepatide substitute Navigating Regulatory Shifts: Alternatives to Compounded for Weight Loss Alternatives to tirzepatide: complete guide

Sitagliptin Sitagliptin is a DPP-4 inhibitor, which exerts its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones

While originally approved for diabetes, Zepbounds recent approval as a weight loss medication increases the number of treatments available

Smoking cessation should be prioritized, as tobacco use promotes systemic inflammation and metabolic dysfunction

PRAC assesses that NAION could be a very rare side effect of Ozempic, Rybelsus and Wegovy Updates of 2 October 2025 The product information for Rybelsus, Ozempic and Wegovy available on EMAs website was updated on 30 September